| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_baee372c55802742f9582e25c15ff11a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-40 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6849
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6889
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2019-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a9c943cd5143edd1dd0a89c1d7c2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2bae89775043c7f6e43b1a85039f35b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6468cf51d1a5a41d9c16007546992d33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a6714812fa46126b5a574b12b72ee06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3c23e48192cb81cb64645b1f73c353d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3658cd73b68bfa7e11c12df7a2b3fc24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2a94897e721a41834752199545ffd76 |
| publicationDate |
2020-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2020019787-A |
| titleOfInvention |
Eribulin-based antibody-drug conjugates and methods of use |
| abstract |
A linker toxin and an antibody-drug conjugate that bind to a human tumor antigen target such as folate receptor alpha and / or exhibit antitubulin drug activity. The disclosed linker toxins and antibody-drug conjugates include an eribulin drug moiety and can be internalized into target antigen-expressing cells. The present disclosure further relates to methods and compositions for use in treating cancer by administering the antibody-drug conjugate. [Selection diagram] None |
| priorityDate |
2016-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |